Get started
Author

Stefan Bentink

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
2006 · Michael Hummel, Stefan Bentink, et al. · New England Journal of Medicine · 1,004
PDF
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
2016 · James McKiernan, Michael J. Donovan, et al. · JAMA Oncology · 691
PDF
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
2017 · A.K. Krug, D. Enderle, et al. · Annals of Oncology · 277
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell
2007 · M Montesinos-Rongen, A Brunn, et al. · Leukemia · 184
A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result
2015 · M J Donovan, M Noerholm, et al. · Prostate Cancer and Prostatic Diseases · 173
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
2008 · José I. Martín-Subero, Markus Kreuz, et al. · Blood · 145
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
2012 · Stefan Bentink, Benjamin Haibe-Kains, et al. · PLoS ONE · 131
PDF
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
2008 · Wolfram Klapper, Monika Szczepanowski, et al. · Blood · 118
PDF
Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status
2008 · Carsten Schwaenen, Andreas Viardot, et al. · Genes Chromosomes and Cancer · 80
Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain
2006 · Teresa Bader, Klaus Schröppel, et al. · Infection and Immunity · 80
CD30-Induced Signaling Is Absent in Hodgkin's Cells but Present in Anaplastic Large Cell Lymphoma Cells
2008 · Burkhard Hirsch, Michael Hummel, et al. · American Journal Of Pathology · 69
PDF
The Functional Basis of Mycophenolic Acid Resistance in Candida albicans IMP Dehydrogenase
2005 · Gerwald A. Köhler, Xin Gong, et al. · Journal of Biological Chemistry · 65
PDF
iBBiG: iterative binary bi-clustering of gene sets
2012 · Daniel Gusenleitner, Eleanor A. Howe, et al. · Bioinformatics · 60
PDF
Similarities of Ordered Gene Lists
2006 · XINAN YANG, STEFAN BENTINK, et al. · Journal of Bioinformatics and Computational Biology · 56
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
2018 · A.K. Krug, D. Enderle, et al. · Annals of Oncology · 55
SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
2012 · Birgit Schif, Jochen K. Lennerz, et al. · Oncotarget · 52
PDF
Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes
2013 · Melissa A. Merritt, Stefan Bentink, et al. · PLoS ONE · 50
PDF
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype
2008 · A Ehlers, E Oker, et al. · Leukemia · 48
Pathway activation patterns in diffuse large B-cell lymphomas
2008 · S Bentink, S Wessendorf, et al. · Leukemia · 44
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma
2008 · J. Dierlamm, E. M. Murga Penas, et al. · Haematologica · 44
PDF
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
2013 · Matthew Schwede, Dimitrios Spentzos, et al. · PLoS ONE · 35
PDF
Therapeutic Implications of GIPC1 Silencing in Cancer
2010 · Thomas W. Chittenden, Jane Pak, et al. · PLoS ONE · 34
PDF
High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas
2011 · Alexandra Schrader, Stefan Bentink, et al. · International Journal of Cancer · 29
PDF
Ataxia Telangiectasia-Mutated Gene Is a Possible Biomarker for Discrimination of Infiltrative Deep Penetrating Nevi and Metastatic Vertical Growth Phase Melanoma
2007 · Alexander Roesch, Bernd Becker, et al. · Cancer Epidemiology Biomarkers & Prevention · 21
Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients
2015 · Kay Brinkmann, Daniel Enderle, et al. · Cancer Research · 15
Works count: 64
Citation count: 3,615
H-index: 23
I10-index: 27
Year
Topic
Type